CCIA
XLRN

Campbell & Co Investment Adviser’s Acceleron Pharma Inc. XLRN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,180
Closed -$208K – 503
2020
Q2 		$208K Buy
+2,180
New +$208K 0.26% 211
2018
Q3 		– Sell
-7,200
Closed -$349K – 568
2018
Q2 		$349K Buy
+7,200
New +$349K 0.27% 144